FdaApplication
NDA 215401
Identifiers
- fda_app_no: NDA215401
Properties
| Property | Value |
|---|---|
| applicant_name | NOVEN PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2022-03-22 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| XELSTRYM | DEXTROAMPHETAMINE | 18MG/9HR | SYSTEM;TRANSDERMAL |
| XELSTRYM | DEXTROAMPHETAMINE | 4.5MG/9HR | SYSTEM;TRANSDERMAL |
| XELSTRYM | DEXTROAMPHETAMINE | 13.5MG/9HR | SYSTEM;TRANSDERMAL |
| XELSTRYM | DEXTROAMPHETAMINE | 9MG/9HR | SYSTEM;TRANSDERMAL |
4 products